Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.68 |
| ▸ | MEN1 | O00255 | 5/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.68 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | APEX1 | P27695 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7907173 | 0.89 | POLB (0.57) | ATMKMT2AMEN1CYP1A2LMNA | |
| SCHEMBL17562151 | 0.89 | KMT2A (0.71) | ATMKMT2AMEN1CYP1A2LMNA | |
| SCHEMBL2736397 | 0.88 | ATM (0.71) | ATMKMT2AMEN1CYP1A2LMNA | |
| SCHEMBL2736392 | 0.87 | ATM (0.66) | ATMKMT2AMEN1CYP1A2LMNA | |
| SCHEMBL21675546 | 0.84 | KMT2A (0.64) | ATMKMT2AMEN1CYP1A2LMNA | |
| SCHEMBL30494683 | 0.82 | KMT2A (0.97) | ATMKMT2AMEN1CYP1A2LMNA | |
| SCHEMBL4393593 | 0.82 | KMT2A (0.97) | ATMKMT2AMEN1CYP1A2LMNA | |
| SCHEMBL2596509 | 0.82 | HDAC3 (0.61) | ATMKMT2AMEN1CYP1A2LMNA | |
| SCHEMBL1419881 | 0.82 | CYP1A2 (0.55) | ATMKMT2AMEN1CYP1A2LMNA | |
| SCHEMBL11716945 | 0.82 | ATM (0.64) | ATMKMT2AMEN1CYP1A2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8114206-B2 | Corrosion resistant coatings with modified metal salts of corrosion resisting organic anions | Lumimove, Inc., A Missouri Corporation, (US) | 2012-02-14 | — | — | US | claimed |
| US-20110236700-A1 | CORROSION RESISTANT COATINGS WITH MODIFIED METAL SALTS OF CORROSION RESISTING ORGANIC ANIONS | LUMIMOVE, INC., A MISSOURI CORPORATION, DBA CROSSLINK (US) | 2011-09-29 | — | — | US | claimed |
| EP-2118342-A2 | CORROSION RESISTANT COATINGS WITH MODIFIED METAL SALTS OF CORROSION RESISTING ORGANIC ANIONS | Crosslink (US) | 2009-11-18 | — | — | EP | claimed |
| WO-2008140648-A9 | CORROSION RESISTANT COATINGS WITH MODIFIED METAL SALTS OF CORROSION RESISTING ORGANIC ANIONS | CROSSLINK (US) | 2009-01-08 | — | — | WO | claimed |
| WO-2008140648-A2 | CORROSION RESISTANT COATINGS WITH MODIFIED METAL SALTS OF CORROSION RESISTING ORGANIC ANIONS | CROSSLINK (US) | 2008-11-20 | — | — | WO | claimed |
| US-20080216705-A1 | Corrosion resistant coatings with modified metal salts of corrosion resisting organic anions | DEPARTMENT OF THE NAVY | 2008-09-11 | — | — | US | claimed |
| WO-2024005461-A1 | NOVEL LINKER COMPOUND AND LIGAND-DRUG CONJUGATE THEREFOR | 주식회사 트리오어 | 2024-01-04 | — | — | WO | disclosed |
| EP-1382721-B1 | Coating for inhibiting oxidation of a substrate | BOEING CO (US) | 2012-06-13 | — | — | EP | disclosed |
| US-8114206-B2 | Corrosion resistant coatings with modified metal salts of corrosion resisting organic anions | Lumimove, Inc., A Missouri Corporation, (US) | 2012-02-14 | — | — | US | disclosed |
| US-20110236700-A1 | CORROSION RESISTANT COATINGS WITH MODIFIED METAL SALTS OF CORROSION RESISTING ORGANIC ANIONS | LUMIMOVE, INC., A MISSOURI CORPORATION, DBA CROSSLINK (US) | 2011-09-29 | — | — | US | disclosed |
| US-7932014-B2 | Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process | CANON KABUSHIKI KAISHA (JP) | 2011-04-26 | — | — | US | disclosed |
| US-20100221656-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | CANON KABUSHIKI KAISHA (JP) | 2010-09-02 | — | — | US | disclosed |
| EP-2118342-A2 | CORROSION RESISTANT COATINGS WITH MODIFIED METAL SALTS OF CORROSION RESISTING ORGANIC ANIONS | Crosslink (US) | 2009-11-18 | — | — | EP | disclosed |
| US-6942899-B2 | Coating for inhibiting oxidation of a substrate | THE BOEING COMPANY (US) | 2005-09-13 | — | — | US | disclosed |
| EP-1382721-A1 | Coating for inhibiting oxidation of a substrate | The Boeing Company (US) | 2004-01-21 | — | — | EP | disclosed |
| US-20040005478-A1 | Coating for inhibiting oxidation of a substrate | BOEING COMPANY, THE | 2004-01-08 | — | — | US | disclosed |
| EP-1098893-B1 | CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS | MERCK PATENT GMBH (DE) | 2003-03-26 | — | — | EP | disclosed |
| US-6528538-B1 | Reaction of 1,3-propanediol derivative with a ketone or aldehyde | MERCK PATENTGESELLSCHAFT (DE) | 2003-03-04 | — | — | US | disclosed |
| EP-1098893-A1 | CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS | MERCK PATENT GmbH (DE) | 2001-05-16 | — | — | EP | disclosed |
| WO-2000004011-A1 | CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDAEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS | MERCK PATENT GMBH (DE) | 2000-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100221656-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | RER1, FRG1, PPOX | ATM 1026/4885KMT2A 943/4885MEN1 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.